Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Generated Narrative: Group 173245
version: 4; Last updated: 2023-12-04 16:25:35+0000
Profile: OutcomeDefinition
Artifact related artifact: No display for RelatedArtifact (type: cite-as; citation: OutcomeDefinition: HbA1c at 36 months [Group]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 173245. Revised 2023-11-23. Available at: https://fevir.net/resources/Group/173245. Computable resource at: https://fevir.net/resources/Group/173245.)
Artifact Author: Brian S. Alper:
url: https://fevir.net/resources/Group/173245
identifier: FEvIR Object Identifier/173245
name: OutcomeDefinition_HbA1c_at_36_months
title: OutcomeDefinition: HbA1c at 36 months
status: Active
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
description:
HbA1c at 36 months
Code | Value[x] |
Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence Communication | OutcomeDefinition |
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
membership: Conceptual
characteristic
code: Observation
value: Hemoglobin A1c/Hemoglobin.total in Blood
exclude: false
description:
HbA1c at 36 months
Timings
ContextCode Offset[x] Text Enrollment in clinical trial No display for Duration (value: 36; unit: months; system: http://unitsofmeasure.org; code: mo) at 36 months